Resazurin Cell Viability Assay
Référence CA035-S
Conditionnement : 2,500assays
Marque : Canvax Biotech
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Resazurin Cell Viability Assay
For a Reliable, Sensitive & Easy-to-use Fluorescent Detection of Cellular Metabolic activity
Resazurin Cell Viability Assay is a reliable, sensitive and easy-to-use fluorescent assay that detects cellular metabolic activity. Resazurin (7-Hydroxy3H-phenoxazin-3-one 10-oxide) is a blue dye non-fluorescent until it is irreversibly reduced to the pink colored and highly red fluorescent resorufin by dehydrogenase enzymes in metabolically active cells.
The fluorescent signal is monitored using 530-560 nm excitation wavelength and 590 nm emission wavelength. The absorbance is monitored at 570 nm and 600 nm. The fluorescent or colorimetric signal generated from the assay is proportional to the number of living cells in the sample.
Detailed information:
- Relevant Cost-Savings.
- Free Samples availables.
- Analoguous Performance/Specifications than higher Products.
- Easy procedure: easy to perform with minimal handling.
- Really convenient and fast protocol: just one step to results.
- Proven performance in a wide range of cell types, including bacteria, yeast, fungi, protozoa, and cultured mammalian cells.
- Highly Sensitive.
- Safe.
- Versatile: compatible with most used instumentation.
– 25 mL Resazurin solution
Datasheet MSDS- Spectrophotometric measurement of metabolic activity of living cells.
t
- Shipped in: Ambient Temperature.
- Storage: It can be stored at 4 °C in the dark for up to 12 months and at –20 °C in the dark for long term storage.
- Guaranteed: All components are stable for at least 10 freeze-thaw cycles.
- Recommendations: Storage in the dark and Thaw Resazurin solution completely and mix thoroughly before use.
- Blázquez-Encinas, R., García-Vioque, V., Caro-Cuenca, T., Moreno-Montilla, M. T., Mangili, F., Alors-Pérez, E., … & Castaño, J. P. (2023). Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
- Jimenez-Vacas, J. M., Montero-Hidalgo, A. J., Gomez-Gomez, E., Saez-Martinez, P., Perez-Gomez, J. M., Fuentes-Fayos, A. C., … & Luque, R. M. (2023). The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancer.
- Mikra, C., Mitrakas, A., Ghizzani, V., Katsani, K. R., Koffa, M., Koukourakis, M., … & Fylaktakidou, K. C. (2023). Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells. International Journal of Molecular Sciences, 24(3), 1834.
- Monteiro-Reis, S., Miranda-Gonçalves, V., Guimarães-Teixeira, C., Martins-Lima, C., Lobo, J., Montezuma, D., … & Jerónimo, C. (2023). Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition. International Journal of Biological Sciences, 19(1), 1.
- Moreira-Silva, F., Outeiro-Pinho, G., Lobo, J., Guimarães, R., Gaspar, V. M., Mano, J. F., … & Jerónimo, C. (2022). G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models. Biomedicine & Pharmacotherapy, 150, 113031.
- Schachtl-Riess, J. F., Coassin, S., Lamina, C., Demetz, E., Streiter, G., Hilbe, R., & Kronenberg, F. (2021). Lysis reagents, cell numbers, and calculation method influence high-throughput measurement of HDL-mediated cholesterol efflux capacity. Journal of Lipid Research, 100125.
- Miranda-Gonçalves, Vera, et al. “The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.” Journal of Experimental & Clinical Cancer Research 40.1 (2021): 1-18.
- Seguí, P., Aguilera-Correa, J. J., Domínguez-Jurado, E., Sánchez-López, C. M., Pérez-Tanoira, R., Ocaña, A. V., … & Molina-Alarcón, M. (2021). A novel bis (pyrazolyl) methane compound as a potential agent against Gram-positive bacteria. Scientific Reports, 11(1), 1-10.
- Pacheco, Mariana Brütt, et al. “Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.” Pharmaceuticals 14.7 (2021): 670.
- León-González, A. J., Sáez-Martínez, P., Jiménez-Vacas, J. M., Herrero-Aguayo, V., Hidalgo, A. J. M., Gómez-Gómez, E., … & Luque, R. M. (2020). Cytotoxic effect of hydroxytyrosol and its semisynthetic derivatives against prostate cancer cells.
- Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H. J., Lopez, M., Arimondo, P. B., … & Jerónimo, C. (2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics 2021, 13, 73.
- Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H., Lopez, M., Arimondo, P. B., … & Jerónimo, C. (2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics, 13(1), 73.
- Ženata, O., Panáček, A., Kvítek, L., & Vrzal, R. (2020). The impact of graphene oxide on androgen receptor signalling in prostate cancer cells. Chemosphere, 128759.
- Sáez Martínez, P., Jiménez-Vacas, J. M., León González, A. J., Herrero-Aguayo, V., Montero-Hidalgo, A. J., Gómez-Gómez, E., … & Luque, R. M. (2020). Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer.
- Zenata, O., Vrzalova, A., Bachleda, P., Janečková, J., Panáček, A., Kvítek, L., & Vrzal, R. (2020). The effect of graphene oxide on signalling of xenobiotic receptors involved in biotransformation. Chemosphere, 126753.
- Boch, M. E. (2018). Effect of Silk-Based Hydrogel Topography on Intestinal Epithelial Cell Morphology and Wound Healing In Vitro.
- Basso, M., Venditti, C., Raponi, G., Navazio, A. S., Alessandri, F., Giombini, E., … & Venditti, M. (2019). A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit. Infection and Drug Resistance, 12, 2391.
This product is developed, designed and sold exclusively for Research purposes and in vitro use only (RUO). The product was not tested for use in diagnostics or for drug development, nor is it suitable for administration to humans or animals. For more info, please check its Material Safety Data Sheet available in this website.